Skip to main content

Empowered Funds, LLC

Source: SEC Form 13F · as of Mar 2026

Empowered Funds, LLC holds 46 biotech & pharma companies tracked by BioSniper, totaling $173.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

46

Total value held

$173.1M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Incyte Corp. (INCY)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
INCYIncyte Corp.353,386$33.3M
GILDGILEAD SCIENCES, INC.195,463$27.2M
EXELEXELIXIS, INC.335,606$14.4M
REGNREGENERON PHARMACEUTICALS, INC.15,618$12.1M
ARWRARROWHEAD PHARMACEUTICALS, INC.137,220$8.6M
INSMINSMED Inc51,986$8.5M
ROIVRoivant Sciences Ltd.285,915$7.9M
IONSIONIS PHARMACEUTICALS INC103,141$7.7M
APLSApellis Pharmaceuticals, Inc.148,038$6.0M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)93,504$5.2M
PTCTPTC THERAPEUTICS, INC.57,906$3.9M
INVAInnoviva, Inc.168,055$3.9M
LQDALiquidia Corp96,717$3.7M
AXSMAxsome Therapeutics, Inc.20,997$3.5M
TGTXTG THERAPEUTICS, INC.85,429$2.8M
JAZZJazz Pharmaceuticals plc14,236$2.7M
TVTXTravere Therapeutics, Inc.84,820$2.5M
BMRNBIOMARIN PHARMACEUTICAL INC33,203$1.9M
ALNYALNYLAM PHARMACEUTICALS, INC.5,410$1.8M
MRNAModerna, Inc.33,436$1.7M
KROSKeros Therapeutics, Inc.145,517$1.6M
NUVLNuvalent, Inc.14,648$1.5M
PBYIPUMA BIOTECHNOLOGY, INC.204,041$1.3M
BHVNBiohaven Ltd.148,756$1.3M
TEVATeva Pharmaceutical Industries Limited37,430$1.1M
ACADACADIA PHARMACEUTICALS INC48,982$1.1M
PCVXVaxcyte, Inc.9,692$563K
LGNDLigand Pharmaceuticals Incorporated2,540$507K
BDTXBlack Diamond Therapeutics, Inc.230,177$490K
SNYSanofi8,858$427K
IMVTImmunovant, Inc.14,556$362K
VKTXViking Therapeutics, Inc.10,219$333K
RVMDREVOLUTION MEDICINES, INC.3,174$309K
ASRTAssertio Holdings, Inc.16,014$305K
DNLIDenali Therapeutics Inc.15,787$303K
NTLAIntellia Therapeutics, Inc.21,410$274K
SUPNSUPERNUS PHARMACEUTICALS, INC.5,107$264K
COGTCogent Biosciences, Inc.6,460$249K
FOLDAMICUS THERAPEUTICS, INC.16,986$246K
PTGXProtagonist Therapeutics, Inc2,321$245K
ARGXARGENX SE294$215K
OVIDOvid Therapeutics Inc.91,234$203K
ONCBeOne Medicines Ltd.676$201K
IRDOpus Genetics, Inc.42,065$191K
SIGASIGA TECHNOLOGIES INC30,316$162K
IBRXImmunityBio, Inc.11,689$90K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.